Impact of nanoencapsulated natural bioactive phenolic metabolites on chitosan nanoparticles as aflatoxins inhibitor.

Aflatoxins are part of fungal secondary metabolites which become serious health, environmental, and economic problems and can cause corruption of many crops and agricultural grains that used as food and feed for human and animal. Aflatoxins mainly produce by Aspergillus spp. especially Aspergillus flavus and Aspergillus parasiticus. The present work aimed to study the effect of nanoencapsulation of chitosan (CS) nanoparticles with two phenolic compounds 1-(2-ethyl,6-heptyl)phenol (EHP) extracted from Cuminum cyminum and 5-ethyl-2-(methoxymethyl)phenol (EMMP) extracted from black pepper on growth and aflatoxins production of A. flavus and A. parasiticus. A. flavus growth was completely inhibited by 0.6 mg/ml of EHP and EMMP as well as A. parasiticus which showed the same minimal inhibition concentration with the first compound and 0.8 mg/ml with the second one. CS nanoparticles inhibited the growth of the tested organisms more than CS especially with A. parasiticus and this potency became much better when nanoencapsulated with the two extracted phenolic compounds. In inhibition of aflatoxins production, EHP reduced the production of aflatoxin B1 and B2 of A. flavus by 68.6% and 69.7%, respectively. In the same manner EMMP reduce the production of the two toxins by 87.3% and 82.6%, respectively. The reduction effect of CS nanoparticles is much more than that of CS as it record in most cases about twofold increase. Nanoencapsulation of CS nanoparticles by the extracted phenolic compounds is much more effective with complete inhibition of aflatoxin B1 of both fungi and aflatoxin G1 of A. parasiticus.